Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
about
Bioresorbable vascular scaffolds technology: current use and future developmentsRole of invasive imaging in acute and long-term assessment of bioresorbable scaffold technology.Long-term outcome of bioresorbable vascular scaffolds for the treatment of coronary artery disease: a meta-analysis of RCTsClinical outcomes of overlapping versus non-overlapping everolimus-eluting absorb bioresorbable vascular scaffolds: An analysis from the multicentre prospective RAI registry (ClinicalTrials.gov identifier: NCT02298413).A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.Bioresorbable vascular scaffold to treat in-stent restenosis: Single-center experience.Recommendations for the use of bioresorbable vascular scaffolds in percutaneous coronary interventions : 2017 revision.Comparison of a Drug-Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3-Year Follow-Up.Bioresorbable scaffolds: the fee comes now and the reward comes later.Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.Bioresorbable Polymers and Stent Devices.Bioresorbable vascular scaffolds - basic concepts and clinical outcome.Update on clinical evidence (Part II): A summary of the main post market studies.Impact of Clinical Presentation on Early Vascular Healing After Bioresorbable Vascular Scaffold Implantation.The Absorb bioresorbable vascular scaffold for the treatment of coronary artery disease.Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.Use of bioresorbable vascular scaffold: a meta-analysis of patients with coronary artery disease.Mid-term and long-term safety and efficacy of bioresorbable vascular scaffolds versus metallic everolimus-eluting stents in coronary artery disease: A weighted meta-analysis of seven randomised controlled trials including 5577 patients.Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice.Bioresorbable vascular scaffolds-time to vanish?How far have we come with bioresorbable vascular scaffolds, and where should we go?Bioresorbable vascular scaffolds for complex coronary anatomies: "Icarus' flight" for interventional cardiologists?The first generation ABSORB BVS scaffold; to be or not to be?Walking the right path: the story of bioresorbable stents.Bioresorbable scaffolds: should we stay simple or go complex?Adverse events with bioresorbable vascular scaffolds in routine percutaneous coronary interventions: "coup de théâtre" or unfinished play?Bioresorbable scaffolds versus metallic stents in routine PCI: the plot thickens.Bioresorbable vascular scaffolds: between promises and reality.Bioresorbable vascular scaffold: promises and the fallen child-as-king?Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience.Thirty-Day and One-Year Clinical Outcomes of Bioresorbable Vascular Scaffold Implantation: A Single-Center Experience.Bioresorbable Vascular Scaffold Korean Expert Panel Report.Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction.Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.New insight to estimate under-expansion after stent implantation on bifurcation lesions using optical coherence tomography.Imaging assessment of bioresorbable vascular scaffolds.
P2860
Q26741147-63CC1EE9-1883-4A00-BCF5-3EAD16EBC64BQ36178330-54A372B7-35F4-4A41-9AE3-E96C7C2ECDF3Q36395245-296A26F1-5300-471A-8959-F9F91633FC56Q38376848-6C558B0C-FF66-428E-95BC-2481D9A052A4Q38385959-E77825E2-0544-47E8-9F42-7937CA6D834EQ38635400-FCBEF7DB-E9C0-4A7B-9AEA-25FC750B3A75Q38712687-5C8D700A-B23B-44C6-B341-B94C1A342800Q38733043-D3C76213-8FAC-472B-AF84-DBB77EEA0652Q38854464-B36E64D7-8ABD-41A4-99DB-79C3095B5DE4Q38885397-8DE42282-2CA4-4889-80DC-978A8BEA4D45Q38904242-A09F7E99-1B2C-490B-BA71-ECD0C121BE8EQ38919254-310D464C-3CDD-4D2B-B14D-5C12F5BC8A87Q38967027-1F7972BB-C46F-416B-9321-7C9C3F95C139Q38994998-9AF48654-A719-42E9-A6C7-9C7E3B2F6571Q39146294-EF38D5DC-FB18-4277-96E1-13D4761F1672Q39465229-BB677C2D-D4A7-4734-942A-A1C0E7F9B258Q39498183-4FAA7079-A88D-43A1-9CFD-F52701C0D60CQ41028884-36ADF11A-150E-4C60-98A0-389A2C0D005BQ41038135-4086532F-AA61-4127-A084-8BAC3291425EQ41607661-8D6EA032-CBD8-4D1B-9AED-C2C98544B084Q41860479-F2D30513-8BA9-4013-A363-EA322D06821FQ42333622-1AF8F2DF-B4AC-4956-87A1-96CC56501E89Q42333628-DFC2AAE5-D10F-43C8-842D-9409B904A4D4Q42334034-08874D96-0E1F-47FF-86A8-1CCD1A5E45FDQ42341962-133C1186-4D27-47AB-9D49-5084333B9A17Q42348038-CAE6A8BB-5C66-4CBD-BEAE-91AD2268ECFDQ42357323-E805CB52-F69D-4F71-8B24-0E69136528D0Q42357329-ACA316BA-4431-4074-953F-C2265EC1F7D9Q42378325-3CC10653-9894-47E1-A7D6-C84C6CFEE880Q42381193-BA8EEA70-7DF3-4B9F-BBB9-276331EB8A65Q42646642-BDB0241C-500B-4370-AA08-4A1A0CEABBB8Q46586855-CD6B5EA3-50FA-4BF9-90DE-90CAD2D5B851Q47111093-D25D8FCA-89D5-44D1-B820-3C5D0EBD25D1Q47131528-915FF733-9747-4F0C-BF35-23DC7E59EF48Q47625273-71B99AA9-176C-4321-80F3-9866A0253279Q47647505-54FB762D-738E-4FD2-B4CC-E74F0AF47CF1Q47686997-00F888F2-A0E0-4F55-BAC6-F13959F918B3Q47723067-B20969D6-0CD1-49FD-8871-9CBBE77B416BQ47809588-74004A50-EFDB-4715-970D-72967B13C0E2Q47854554-B1B9328F-A866-4030-BEB5-2C61C621DAB9
P2860
Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@en
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@nl
type
label
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@en
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@nl
prefLabel
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@en
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@nl
P2093
P1476
Bioresorbable Coronary Scaffol ...... n, Mechanisms, and Predictors.
@en
P2093
Axel Schmermund
Florim Cuculi
Harald Binder
Holger Eggebrecht
Melissa Weissner
Peiman Jamshidi
Serban Puricel
Stephane Cook
Thomas Münzel
Tobias Nyffenegger
P304
P356
10.1016/J.JACC.2015.12.019
P407
P577
2016-03-01T00:00:00Z